Showing results (1071-1080 of 1,520) with videos related to

Sort By:
Pageof 152
Physical Review Letters|August 29, 2014
Precision measurement of the hydrogen 1S-2S frequency via a 920-km fiber linkArthur Matveev, Christian G Parthey, Katharina Predehl, et al.
Scientific Reports|December 12, 2019
Optical coherence angiography for pre-treatment assessment and treatment monitoring following photodynamic therapy: a basal cell carcinoma patient studyE V Gubarkova, F I Feldchtein, E V Zagaynova, et al.
Arkhiv Patologii|June 12, 2009
[Detection of oncoprotein E7 HPV16 in the cancer and normal urinary bladder urothelium]G M Volgareva, L E Zavalishina, D A Golovina, et al.
Biomedical Optics Express|June 21, 2023
Compression OCT-elastography combined with speckle-contrast analysis as an approach to the morphological assessment of breast cancer tissueAnton A Plekhanov, Ekaterina V Gubarkova, Marina A Sirotkina, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 18, 2024
Remarkable Effect of Stereoisomerism on the Am(III)/Ln(III) Solvent Extraction. New Ligands for Highly Efficient Separation of AmericiumValentine S Petrov, Pavel S Lemport, Mariia V Evsiunina, et al.
Cancer Research|July 29, 2010
Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variantsLee E Moore, Paolo Boffetta, Sara Karami, et al.
Arkhiv Patologii|November 20, 2010
[Are human papillomaviruses responsible for the occurrence of bladder cancer]G M Volgareva, L É Zavalishina, O B Trofimova, et al.
Nature Structural & Molecular Biology|April 9, 2025
Ion-conducting and gating molecular mechanisms of channelrhodopsin revealed by true-atomic-resolution structures of open and closed statesDmitrii Zabelskii, Sergey Bukhdruker, Siarhei Bukhalovich, et al.
The Lancet. Oncology|June 8, 2013
Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trialIan F Tannock, Karim Fizazi, Sergey Ivanov, et al.
International Journal of Cancer|June 9, 2023
Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trialSun Young Rha, Toni K Choueiri, Vsevolod B Matveev, et al.
Pageof 152